Abstract
Psychiatric disorders are prevalent conditions that affect hundreds of millions of people worldwide (World Health Organization, 2004). Although rates vary depending on the definition used, epidemiological research suggests that nearly 50 % of individuals will at some point in their lives meet diagnostic criteria for a psychiatric condition from among anxiety, mood, substance use, and impulse control disorders (Kessler et al., 2005). Each year, an estimated 26.2 % of adults (Kessler, Chiu, Demler, & Walters, 2005) and between 6.1 % and 40.3 % of children and adolescents (Kessler et al., 2012; Roberts, Attkisson, & Rosenblatt, 1998) experience at least one psychiatric disorder, with more than 40 % of these individuals also suffering from other comorbid conditions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alonso, J. J., Petukhova, M. M., Vilagut, G. G., Chatterji, S. S., Heeringa, S. S., Ustun, T. B., … Kessler, R. C. (2011). Days out of role due to common physical and mental conditions: Results from the WHO World Mental health surveys. Molecular Psychiatry, 16, 1234–1246.
American Psychological Association Presidential Task Force on Evidence-Based Practice. (2006). Evidence-based practice in psychology. American Psychologist, 61, 271–285.
Andrews, P., Kornstein, S., Halberstadt, L., Gardner, C., & Neale, M. C. (2011). Blue again: Perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression. Frontiers in Psychology, 2. Retrieved from http://www.frontiersin.org/Evolutionary_Psychology/10.3389/fpsyg.2011.00159/full.
Angermeyer, M. C., Holzinger, A., & Matschinger, H. (2009). Mental health literacy and attitude towards people with mental illness: A trend analysis based on population surveys in the eastern part of Germany. European Psychiatry, 24, 225–232.
Angermeyer, M. C., & Matschinger, H. (2005). Causal beliefs and attitudes to people with schizophrenia. Trend analysis based on data from two population surveys in Germany. British Journal of Psychiatry, 186, 331–334.
Arch, J. J. (2014). Cognitive behavioral therapy and pharmacotherapy for anxiety: Treatment preferences and credibility among pregnant and non-pregnant women. Behaviour Research and Therapy, 52, 53–60.
Becker, E. M., Smith, A. M., & Jensen-Doss, A. (2013). Who’s using treatment manuals? A national survey of practicing therapists. Behaviour Research and Therapy, 51, 706–710.
Becker, C., Zayfert, C., & Anderson, E. (2004). A survey of psychologists’ attitude towards the utilization of exposure therapy for PTSD. Behaviour Research and Therapy, 42, 277–292.
Belzer, K., & Schneier, F. R. (2004). Comorbidity of anxiety and depressive disorders: Issues in conceptualization, assessment, and treatment. Journal of Psychiatric Practice, 10, 296–306.
Bickman, L., Douglas Kelley, S., Breda, C., Regina de Andrade, A., & Riemer, M. (2011). Effects of routine feedback to clinicians on mental health outcomes of youths: Results of a randomized trial. Psychiatric Services, 62, 1423–1429.
Binks, C. A., Fenton, M., McCarthy, L., Lee, T., Adams, C. E., & Duggan, C. (2006). Pharmacological interventions for people with borderline personality disorder. Cochrane Database of Systematic Reviews, 1, CD005653.
Borntrager, C., & Lyon, A. R. (2015). Client progress monitoring and feedback in school-based mental health. Cognitive and Behavioral Practice, 22(1), 74–86.
Butler, A. C., Chapman, J. E., Forman, E. M., & Beck, A. T. (2006). The empirical status of cognitive-behavioral therapy: A review of meta-analyses. Clinical Psychology Review, 26, 17–31.
Byrne, S. L., Hooke, G. R., Newnham, E. A., & Page, A. C. (2012). The effects of progress monitoring on subsequent readmission to psychiatric care: A six-month follow-up. Journal of Affective Disorders, 137, 113–116.
Carlier, I. V. E., Meuldjik, D., Van Vliet, I. M., Van Fenema, E., Van der Wee, N. J. A., & Zitman, F. G. (2012). Routine outcome monitoring and feedback on physical or mental health status: Evidence and theory. Journal of Evaluation in Clinical Practice, 18, 104–110.
Chambless, D. L., & Ollendick, T. H. (2001). Empirically supported psychological interventions: Controversies and evidence. Annual Review of Psychology, 52, 685–716.
Chang, T.E., Jing, Y., Yeung, A.S., Brenneman, S.K., Kalsekar, I., Hebden, T., … Fava, M. (2012). Effect of communicating depression severity on physician prescribing patterns: Findings from the clinical outcomes in measurement-based treatment (COMET) trial. General Hospital Psychiatry, 34, 105–112.
Chang, E. T., Wells, K. B., Gilmore, J., Tang, L., Morgan, A. U., Sanders, S., & Chung, B. (2015). Comorbid depression and substance abuse among safety-net clients in Los Angeles: A community participatory study. Psychiatric Services, 66, 285–294.
Comer, J. S., Olfson, M., & Mojtabai, R. (2010). National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007. Journal of the American Academy of Child & Adolescent Psychiatry, 49, 1001–1010.
Cook, J. M., Schnurr, P. P., Biyanova, T., & Coyne, J. C. (2009). Apples don’t fall far from the tree: Influences on psychotherapists’ adoption and sustained use of new therapies. Psychiatric Services, 60, 671–676.
De Hert, M., Cohen, D., Bobes, J., Cetkovich-Bakmas, M., Leucht, S., Ndetei, D.M., … Correll, C.U. (2011). Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry, 10, 138–151.
De Hert, M., Correll, C. U., Bobes, J., Cetkovich-Bakmas, M., Cohen, D., Asai, I., … Leucht, S. (2011). Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry, 10, 52–77.
Deacon, B. J. (2013). The biomedical model of mental disorder: A critical analysis of its validity, utility, and effects on psychotherapy research. Clinical Psychology Review, 33, 846–861.
Devilly, G. J. (2005). Power Therapies and possible threats to the science of psychology and psychiatry. Australian and New Zealand Journal of Psychiatry, 39, 437–445.
Dietrich, S., Beck, M., Bujantugs, B., Kenzine, D., Matschinger, H., & Angermeyer, M. C. (2004). The relationship between public causal beliefs and social distance toward mentally ill people. Australian and New Zeland Journal of Psychiatry, 38, 348–357.
Dietrich, S., Matschinger, H., & Angermeyer, M. C. (2006). The relationship between biogenetic causal explanations and social distance toward people with mental disorders: Results from a population survey in Germany. International Journal of Social Psychiatry, 52, 166–174.
Druss, B. G., Hwang, I. I., Petukhova, M. M., Sampson, N. A., Wang, P. S., & Kessler, R. C. (2009). Impairment in role functioning in mental and chronic medical disorders in the United States: Results from the National Comorbidity Survey Replication. Molecular Psychiatry, 14, 728–737.
Duffy, F. F., Chung, H., Trivedi, M., Rae, D. S., Regier, D. A., & Katzelnick, D. J. (2008). Systematic use of patient-rated depression severity monitoring: Is it helpful and feasible in clinical psychiatry? Psychiatric Services, 59, 1148–1154.
Epstein, J. N., Langberg, J. M., Lichtenstein, P. K., Kolb, R. C., & Simon, J. O. (2013). The myADHDportal.com improvement program: An innovative quality improvement intervention for improving the quality of ADHD care among community-based pediatricians. Clinical Practice in Pediatric Psychology, 1, 55–67.
Fava, M., Alpert, J. E., Carmin, C. N., Wisniewski, S. R., Trivedi, M. H., Biggs, M. M., … Rush, A. J. (2004). Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychological Medicine, 34, 1299–1308.
Fervaha, G., Agid, O., Takeuchi, H., Foussias, G., & Remington, G. (2014). Effect of antipsychotic medication on overall life satisfaction among individuals with chronic schizophrenia: Findings from the NIMH CATIE study. European Neuropsychopharmacology, 4(7), 1078–1085.
First, M. B., Spitzer, R. L., Williams, J. B., & Gibbon, M. (1997). Structured clinical interview for DSM-IV (SCID). Washington, DC: American Psychiatric Association.
Foa, E. B. (2010). Cognitive behavioral therapy of obsessive-compulsive disorder. Dialogues in Clinical Neuroscience, 12, 199–207.
Frosch, D. L., & Grande, D. (2010). Direct-to-consumer advertising prescription drugs. LDI Issue Brief, 15, 1–4.
Garland, A. F., Kruse, M., & Aarons, G. A. (2003). Clinicians and outcome measurement: What’s the use? Journal of Behavioral Health Services Research, 30, 393–405.
Garland, A. F., Bickman, L., & Chorpita, B. F. (2010). Change what? Identifying quality improvement targets by investigating usual mental health care. Administration and Policy in Mental Health and Mental Health Services Research, 37, 15–26.
Gaudiano, B. A., Brown, L. A., & Miller, I. W. (2011a). Factors associated with critical thinking abilities in psychotherapists. Cognitive Behaviour Therapy, 40, 137–146.
Gaudiano, B. A., Brown, L. A., & Miller, I. W. (2011b). Let your intuition be your guide? Individual differences in the evidence-based practice attitudes of psychotherapists. Journal of Evaluation in Clinical Practice, 17, 628–634.
Gaudiano, B. A., Brown, L. A., & Miller, I. W. (2012). Tapping their patients’ problems away? Characteristics of psychotherapists using energy meridian techniques. Research on Social Work Practice, 22, 647–655.
Gaudiano, B. A., & Herbert, J. D. (2000). Can we really tap away our problems? A critical analysis of thought field therapy. Skeptical Inquirer, 24(4), 29–33. 36.
Ghaemi, N., Sachs, G. S., & Goodwin, F. K. (2000). What is to be done? Controversies in the diagnosis and treatment of manic-depressive illness. The World Journal of Biological Psychiatry, 1(2), 65–74.
Gilbody, S., House, A., & Sheldon, T. (2002). Psychiatrists in the UK do not use outcomes measures. British Journal of Psychiatry, 180, 101–103.
Gilbody, S., Wilson, P., & Watt, I. (2004). Direct-to-consumer advertising of psychotropics. An emerging and evolving form of pharmaceutical company influence. British Journal of Psychiatry, 185, 1–2.
Haby, M. M., Tonge, B., Littlefield, L., Carter, R., & Vos, T. (2004). Cost-effectiveness of cognitive behavioural therapy and selective serotonin reuptake inhibitors for major depression in children and adolescents. Australian and New Zealand Journal of Psychiatry, 38, 579–591.
Haddad, P., Dursun, S., & Deakin, B. (Eds.). (2004). Adverse syndromes and psychiatric drugs: A clinical guide. New York, NY: Oxford University Press.
Hans, E., & Hiller, W. (2013). Effectiveness of and dropout from outpatient cognitive behavioral therapy for adult unipolar depression: A meta-analysis of nonrandomized effectiveness studies. Journal of Consulting and Clinical Psychology, 81, 75–88.
Herbert, J. D., Lilienfeld, S. O., Lohr, J. M., Montgomery, R. W., O'Donohue, W. T., Rosen, G. M., … Tolin, D. F. (2000). Science and pseudoscience in the development of eye movement desensitization and reprocessing: Implications for clinical psychology. Clinical Psychology Review, 20, 945–971.
Heuzenroede, L., Donnelly, M., Haby, M. M., Mihalopoulos, C., Rossell, R., Carter, R., … Vos, T. (2004). Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder. Australian and New Zealand Journal of Psychiatry, 38, 602–612.
Hirschfeld, R. M., Cass, A. R., Holt, D. C., & Carlson, C. A. (2005). Screening for bipolar disorder in patients treated for depression in a family medicine clinic. Journal of the American Board of Family Practice, 18, 233–239.
Hirschfeld, R. M., & Vornik, L. A. (2004). Recognition and diagnosis of bipolar disorder. Journal of Clinical Psychiatry, 65(Suppl 15), 5–9.
Hollon, S. D., DeRubeis, R. J., Shelton, R. C., Amsterdam, J. D., Salomon, R. M., O'Reardon, J. P., … Gallop, R. (2005). Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Archives of General Psychiatry, 62, 417–422.
Horowitz, L. M., Snyder, D., Ludi, E., Rosenstein, D. L., Kohn-Godbout, Lee, L., … Pao, M. (2013). Ask suicide-screening questions to everyone in medical settings: the asQ-em quality improvement project. Psychosomatics, 54, 239–247.
Hunkeler, E. M., Hargreaves, W. A., Fireman, B., Terdiman, J., Meresman, J. F., Porterfield, Y., … Taylor, C.B. (2012). A web-delivered care management and patient self-management program for recurrent depression: A randomized trial. Psychiatric Services, 63, 1063–1071.
IMS Institute for Healthcare Informatics. (2012). The use of medicines in the United States: Review of 2011. Parsippany, NJ: Author.
Institute of Medicine. (2007). Treatment of PTSD: An assessment of the evidence. Washington, DC: National Academic Press.
Katon, W. J., Lin, E. H., Von Korff, M., Ciechanowski, P., Ludman, E. J., Young, B., … McCulloch, D. (2010). Collaborative care for patients with depression and chronic illnesses. New England Journal of Medicine, 363, 2611–2620.
Katon, W., Russo, J., Lin, E. H., Schmittdiel, J., Ciechanowski, P., Ludman, E., … Von Korff, M. (2012). Cost-effectiveness of a multicondition collaborative care intervention: A randomized controlled trial. Archives of General Psychiatry, 69, 506–514.
Kessler, R. C., Avenevoli, S., Costello, E., Georgiades, K., Green, J., Gruber, M. J., … Merikangas, K. (2012). Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement. Archives of General Psychiatry, 69, 372–380.
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV Disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 593–602.
Kessler, R. C., Chiu, W., Demler, O., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV Disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 617–627.
Kessler, R. C., Demler, O., Frank, R. G., Olfson, M., Pincus, H., Walters, E. E., … Zaslavsky, A. M. (2005). Prevalence and treatment of mental disorders, 1990 to 2003. New England Journal of Medicine, 352, 2515–2523.
Kravitz, R. L., Epstein, R. M., Feldman, M. D., Franz, C. E., Azari, R., Wilkes, M. S., … Franks, P. (2005). Influence of patients' requests for direct-to-consumer advertised antidepressants: A randomized controlled trial. Journal of the American Medical Association, 293, 1995–2002.
Kvaale, E. P., Gottdiener, W. H., & Haslam, N. (2013). Biogenetic explanations and stigma: A meta-analytic review of associations among laypeople. Social Science & Medicine, 96, 95–103.
Lacasse, J. R., & Leo, J. (2005). Serotonin and depression: A disconnect between the advertisements and the scientific literature. PLoS Medicine, 2, e392.
Lambert, M. J., Hansen, N. B., & Finch, A. E. (2001). Patient-focused research: Using patient outcome data to enhance treatment effects. Journal of Consulting and Clinical Psychology, 69, 159–172.
Lambert, M. J., Whipple, J. L., Hawkins, E. J., Vermeersch, D. A., Nielsen, S. L., & Smart, D. W. (2003). Is it time for clinicians to routinely track patient outcome? A meta-analysis. Clinical Psychology: Science and Practice, 10, 288–301.
Lieberman, J., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., … Hsiao, J.K. (2005). Clinical antipsychotic trials of intervention effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine, 353, 1209–1223.
Lilienfeld, S. O. (2014). The dodo bird verdict: Status in 2014. The Behavior Therapist, 37, 91–95.
Lilienfeld, S. O., Ritschel, L. A., Lynn, S. J., Cautin, R. L., & Latzman, R. D. (2013). Why many clinical psychologists are resistant to evidence-based practice: Root causes and constructive remedies. Clinical Psychology Review, 33, 883–900.
Lowe, B., Schulz, U., Grafe, K., & Wilke, S. (2006). Medical patients’ attitudes toward emotional problems and their treatment. What do they really want? Journal of General Internal Medicine, 21, 39–45.
Luborsky, L., Singer, B., & Luborsky, L. (1975). Comparative studies of psychotherapies: Is it true that “Everyone has won and all must have prizes”? Archives of General Psychiatry, 32, 995–1008.
Mahoney, J. S., Ellis, T. E., Garland, G., Palyo, N., & Greene, P. (2012). Supporting a psychiatric hospital culture of safety. Journal of the American Psychiatric Nurses Association, 18, 299–306.
Marcus, S. C., & Olfson, M. (2010). National trends in the treatment for depression from 1998 to 2007. Archives of General Psychiatry, 67, 1265–1273.
Mash, E., & Hunsley, J. (2005). Evidence-based assessment of child and adolescent disorders: Issues and challenges. Journal of Clinical Child and Adolescent Psychology, 34, 362–379.
McHugh, R. K., & Barlow, D. H. (2010). The dissemination and implementation of evidence-based psychological treatments. A review of current efforts. American Psychologist, 65, 73–84.
McHugh, R. K., Whitton, S. W., Peckham, A. D., Welge, J. A., & Otto, M. W. (2013). Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: A meta-analytic review. Journal of Clinical Psychiatry, 74, 595–602.
Miklowitz, D. J. (2008). Adjunctive psychotherapy for bipolar disorder: State of the evidence. American Journal of Psychiatry, 165, 1408–1419.
Miklowitz, D. J., Otto, M. W., Frank, E., Reilly-Harrington, N. A., Wisniewski, S. R., Kogan, J. N., … Sachs, G.S. (2007). Psychosocial treatments for bipolar depression: A 1-year randomized trial from the Systematic Treatment Enhancement Program. Archives of General Psychiatry, 64, 419–426.
Mintzes, B., Barer, M. L., Kravitz, R. L., Kazanjian, A., Bassett, K., Lexchin, J., … Marion, S. A. (2002). Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: Two site cross sectional survey. British Medical Journal, 324, 278–279.
National Institute for Health and Clinical Excellence. (2005). Obsessive-compulsive disorder: Core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder. London: Author.
O’Donahue, W. T., & Engle, J. L. (2014). Errors in psychological practice: Devising a system to improve client safety and well-being. Professional Psychology: Research and Practice, 44, 314–323.
Olfson, M., & Marcus, S. C. (2009). National patterns in antidepressant medication treatment. Archives of General Psychiatry, 66, 848–856.
Olfson, M., & Marcus, S. C. (2010). National trends in outpatient psychotherapy. American Journal of Psychiatry, 167, 1456–1463.
Pescosolido, B. A., Martin, J. K., Long, J. S., Medina, T. R., Phelan, J. C., & Link, B. G. (2010). “A disease like any other”? A decade of change in public reactions to schizophrenia, depression, and alcohol dependence. American Journal of Psychiatry, 167, 1321–1330.
Petersen, T., Andreotti, C. F., Chelminski, I., Young, D., & Zimmerman, M. (2009). Do comorbid anxiety disorders impact treatment planning for outpatients with major depressive disorder? Psychiatry Research, 169, 7–11.
Pignotti, M., & Thyer, B. A. (2009). Use of novel unsupported and empirically supported therapies by licensed clinical social workers: An exploratory study. Social Work Research, 33, 5–17.
Pigott, H. H., Leventhal, A. M., Alter, G. S., & Boren, J. J. (2010). Efficacy and effectiveness of antidepressants: Current status of research. Psychotherapy and Psychosomatics, 79, 267–279.
Pincus, H., Tanielian, T. L., Marcus, S. C., Olfson, M., Zarin, D. A., Thompson, J., … Zito, J. (1998). Prescribing trends in psychotropic medications: Primary care, psychiatry, and other medical specialities. Journal of the American Medical Association, 279, 526–531.
Posternak, M. A., & Zimmerman, M. (2007). Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials: Meta-analysis. British Journal of Psychiatry, 190, 287–292.
Roberts, R. E., Attkisson, C., & Rosenblatt, A. (1998). Prevalence of psychopathology among children and adolescents. American Journal of Psychiatry, 155, 715–725.
Rosen, G. M., & Davidson, G. C. (2003). Psychology should list empirically supported principles of change (ESPs) and not credential trademarked therapies or other treatment packages. Behavior Modification, 27, 300–312.
Roshanaei-Moghaddam, B., Pauly, M. C., Atkins, D. C., Baldwin, S. A., Stein, M. B., & Roy-Byrne, P. (2011). Relative effects of CBT and pharmacotherapy in depression versus anxiety: Is medication somewhat better for depression, and CBT somewhat better for anxiety? Depression and Anxiety, 28, 560–567.
Roy-Byrne, P., Craske, M. G., Sullivan, G., Rose, R. D., Edlund, M. J., … & Stein, M. B. (2010). Delivery of evidence-based treatment for multiple anxiety disorders in primary care: A randomized controlled trial. Journal of the American Medical Association, 303, 1921–1928.
Rozensky, R. H. (2011). The institution of the institutional practice of psychology: Health care reform and psychology’s future workforce. American Psychologist, 66, 797–808.
Rusch, L. C., Kanter, J. W., & Brondino, M. J. (2009). A comparison of contextual and biomedical models of stigma reduction for depression with a nonclinical undergraduate sample. Journal of Nervous and Mental Disease, 197, 104–110.
Ruths, S., Sorensen, P., Kirkevold, O., Husebo, B. S., Kruger, K., Halvoresen, K. H., … Selbaek, G. (2013). Trends in psychotropic drug prescribing in Norwegian nursing homes from 1997 to 2009: A comparison of six cohorts. International Journal of Geriatric Psychiatry, 28, 868–876.
Sachs, G. S., Nierenberg, A. A., Calabrese, J. R., Marangell, L. B., Wisniewski, S. R., Gyulai, L., … Thase, M.E. (2007). Effectiveness of adjunctive antidepressant treatment for bipolar depression. New England Journal of Medicine, 356, 1711–1722.
Sava, F. A., Yates, B. T., Lupu, V., Szentagotai, A., & David, D. (2009). Cost-effectiveness and cost-utility of cognitive therapy, rational emotive behavioral therapy, and fluoxetine (Prozac) in treating depression: A randomized clinical trial. Journal of Clinical Psychology, 65, 36–52.
Sharma, V. (2006). Treatment resistance in unipolar depression: Is it an iatrogenic phenomenon caused by antidepressant treatment of patients with a bipolar diathesis? Medical Hypotheses, 67, 1142–1145.
Sharp, I. R., Herbert, J. D., & Redding, R. (2008). The role of critical thinking in practicing psychologists’ theoretical orientation and choice of intervention techniques. The Scientific Review of Mental Health Practice, 6, 21–30.
Sherbourne, C. D., Wells, K. B., Duan, N., Miranda, J., Unützer, J., Jaycox, L., … Rubenstein, L. V. (2001). Long-term effectiveness of disseminating quality improvement for depression in primary care. Archives of General Psychiatry, 58, 696–703.
Smit, F., Cuijpers, P., Oostenbrink, J., Batelaan, N., de Graaf, R., & Beekman, A. (2006). Costs of nine common mental disorders: Implications for curative and preventive psychiatry. Journal of Mental Health Policy and Economics, 9, 193–200.
Southam-Gerow, M. A., Weisz, J. R., Chu, B. C., McLeod, B. D., Gordis, E. B., & Connor-Smith, J. K. (2010). Does cognitive behavioral therapy for youth anxiety outperform usual care in community clinics? An initial effectiveness test. Journal of the American Academy of Child & Adolescent Psychiatry, 49, 1043–1052.
Spielmans, G. I., Berman, M. I., & Usitalo, A. N. (2011). Psychotherapy versus second-generation antidepressants in the treatment of depression: A meta-analysis. Journal of Nervous and Mental Disease, 199, 142–149.
Spring, B. (2007). Evidence-based practice in clinical psychology: What it is, why it matters; what you need to know. Journal of Clinical Psychology, 63, 611–631.
Stewart, R. E., & Chambless, D. L. (2009). Cognitive-behavioral therapy for adult anxiety disorders in clinical practice: A meta-analysis of effectiveness studies. Journal of Consulting and Clinical Psychology, 77, 595–606.
Sullivan, G., Sherbourne, C., Chavira, D .A., Craske, M. G., Gollineli, D., Han, X., … Roy-Byrne, P. (2013). Does a quality improvement intervention for anxiety result in differential outcomes for lower-income patients? American Journal of Psychiatry, 170, 218–225.
Toh, S., Li, Q., Cheetham, T., Cooper, W. O., Davis, R. L., Dublin, S., … Andrade, S. E. (2013). Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001–2007: A population-based study of 585,615 deliveries. Archives of Women’s Mental Health, 16, 149–157.
Tolin, D. F. (2010). Is cognitive–behavioral therapy more effective than other therapies? A meta-analytic review. Clinical Psychology Review, 30, 710–720.
Trivedi, M. H., Rush, A. J., Gaynes, B. N., Stewart, J. W., Wisniewski, S. R., Warden, D., … Howland, R. (2007). Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR*D measurement-based care. Neuropsychopharmacology, 32, 2479–2489.
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., … Fava M. (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR * D: implications for clinical practice. American Journal of Psychiatry, 163, 28–40.
Unützer, J., Katon, W., Callahan, C. M., Williams, J. W. Jr., Hunkeler, E., Harpole, L., … Langston, C. (2002). Collaborative care management of late-life depression in the primary care setting: A randomized controlled trial. Journal of the American Medical Association, 288, 2836–2845.
Verdoux, H. H., Tournier, M. M., & Begaud, B. B. (2010). Antipsychotic prescribing trends: A review of pharmaco-epidemiological studies. Acta Psychiatrica Scandinavica, 121, 4–10.
Vos, T., Corry, J., Haby, M. M., Carter, R., & Andrews, G. (2005). Cost-effectiveness of cognitive-behavioural therapy and drug interventions for major depression. Australian and New Zealand Journal of Psychiatry, 39, 683–692.
Vos, T., Haby, M. M., Magnus, A., Mihalopoulos, C., Andrews, G., & Carter, R. (2005). Assessing cost-effectiveness in mental health: Helping policy-makers prioritize and plan health services. Australian and New Zealand Journal of Psychiatry, 39, 701–712.
Waller, G., Stringer, H., & Meyer, C. (2012). What cognitive behavioral techniques do therapists report using when delivering cognitive behavioral therapy for the eating disorders? Journal of Consulting and Clinical Psychology, 80, 171–175.
Weiss, A. P., Guidi, J., & Fava, M. (2009). Closing the efficacy-effectiveness gap: Translating both the what and the how from randomized controlled trials to clinical practice. Journal of Clinical Psychiatry, 70, 446–449.
Weisz, J. R., Southam-Gerow, M. A., Gordis, E. B., Connor-Smith, J. K., Chu, B. C., Langer, D. A., … Weiss, B. (2009). Cognitive-behavioral therapy versus usual clinical care for youth depression: An initial test of transportability to community clinics and clinicians. Journal of Consulting and Clinical Psychology, 77, 383–396.
Wells, K. B., Jones, L., Chung, B., Dixon, E. L., Tang, L., Gilmore, J., … Miranda, J. (2013). Community-partnered cluster-randomized comparative effectiveness trial of community engagement and planning or resources for services to address depression disparities. Journal of General Internal Medicine, 28, 1268–1278.
World Health Organization. (2003). Quality improvement for mental health. Geneva, Switzerland: WHO Press.
World Health Organization. (2004). The global burden of disease: 2004 update. Geneva, Switzerland: WHO Press.
Wu, C.-S., Wang, C.-C., Katz, A. J., & Farley, J. (2013). National trends of psychotropic medication use among patients diagnosed with anxiety disorders: Results from Medical Expenditure Panel Survey 2004-2009. Journal of Anxiety Disorders, 27, 163–170.
Yatham, L. N. (2005). Diagnosis and management of patients with bipolar II disorder. Journal of Clinical Psychiatry, 66(Suppl 1), 13–17.
Yeung, A. S., Jing, Y., Brenneman, S. K., Chang, T. E., Baer, L., Hebden, T., … Fava, M. (2012). Clinical Outcomes in Measurement-Based Treatment (COMET): A trial of depression monitoring and feedback to primary care physicians. Depression and Anxiety, 29, 865–873.
Zimmerman, M., & Chelminski, I. (2003). Clinician recognition of anxiety disorders in depressed outpatients. Journal of Psychiatric Research, 37, 325–333.
Zimmerman, M., & Mattia, J. I. (1999). Psychiatric diagnosis in clinical practice: Is comorbidity being missed? Comprehensive Psychiatry, 40, 182–191.
Zimmerman, M., & McGlinchey, J. B. (2008). Why don’t psychiatrists use scales to measure outcome when treating depressed patients? Journal of Clinical Psychiatry, 69, 1916–1919.
Zimmerman, M., Ruggero, C. J., Chelminski, I., & Young, D. (2008). Is bipolar disorder overdiagnosed? Journal of Clinical Psychiatry, 69, 935–940.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Gaudiano, B.A., Dalrymple, K.L., D’Avanzato, C., Bunaciu, L. (2016). The Need for Quality Improvement in Behavioral Health. In: O'Donohue, W., Maragakis, A. (eds) Quality Improvement in Behavioral Health. Springer, Cham. https://doi.org/10.1007/978-3-319-26209-3_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-26209-3_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-26207-9
Online ISBN: 978-3-319-26209-3
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)